- Home
- IH vs ACHV Comparison
IH vs ACHV Comparison
Compare IH & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- ACHV
- Stock Information
- Founded
- IH 1996
- ACHV N/A
- Country
- IH China
- ACHV United States
- Employees
- IH N/A
- ACHV N/A
- Industry
- IH Other Consumer Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IH Real Estate
- ACHV Health Care
- Exchange
- IH Nasdaq
- ACHV Nasdaq
- Market Cap
- IH 146.3M
- ACHV 167.6M
- IPO Year
- IH 2020
- ACHV N/A
- Fundamental
- Price
- IH $2.68
- ACHV $4.97
- Analyst Decision
- IH
- ACHV Strong Buy
- Analyst Count
- IH 0
- ACHV 1
- Target Price
- IH N/A
- ACHV $12.00
- AVG Volume (30 Days)
- IH 15.1K
- ACHV 2.3M
- Earning Date
- IH 09-18-2025
- ACHV 11-07-2025
- Dividend Yield
- IH 3.06%
- ACHV N/A
- EPS Growth
- IH N/A
- ACHV N/A
- EPS
- IH 0.29
- ACHV N/A
- Revenue
- IH $123,215,612.00
- ACHV N/A
- Revenue This Year
- IH $39.02
- ACHV N/A
- Revenue Next Year
- IH N/A
- ACHV N/A
- P/E Ratio
- IH $9.71
- ACHV N/A
- Revenue Growth
- IH N/A
- ACHV N/A
- 52 Week Low
- IH $1.47
- ACHV $1.84
- 52 Week High
- IH $3.60
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- IH 43.20
- ACHV 75.92
- Support Level
- IH $2.65
- ACHV $4.72
- Resistance Level
- IH $2.89
- ACHV $5.78
- Average True Range (ATR)
- IH 0.21
- ACHV 0.33
- MACD
- IH -0.02
- ACHV 0.16
- Stochastic Oscillator
- IH 6.71
- ACHV 71.46
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.